To the best of our knowledge, this is the first retrospective real-life analysis that highlights the relationship between Ki67 expression and PFS in ABC patients treated with endocrine therapy plus commercially available CDK4/6i. This evidence concerns the gene CDK4 and aneurysmal bone cyst.